MOUNTAIN VIEW, Calif. — These days, DNA testing is making headlines in politics and criminal justice — and genetic privacy is increasingly in the spotlight.

At 23andMe, the industry’s best-known company, the executive tasked with thinking about safeguarding DNA is global privacy officer Kate Black.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

  • Agreed, can’t they just summarize what the article is about? Is 23andme for it, against it, or just want to sell the information to insurance companies so I can be denied insurance because they think I have an increased risk of variant CJD or something?

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy